Pleomorphic lobular carcinoma of the breast: Role of comprehensive molecular pathology in characterization of an entity

Journal of Pathology

Volumn 207, Issue 1, 2005, Pages 1-13

  Reis Filho, Jorge S ^a,b   Simpson, Pete T ^a,c   Jones, Chris ^a   Steele, Dawn ^a   Mackay, Alan ^a   Iravani, Marjan ^a   Fenwick, Kerry ^a   Valgeirsson, Haukur ^a   Lambros, Maryou ^a   Ashworth, Alan ^a   Palacios, Jose ^d   Schmitt, Fernando ^b   Lakhani, Sunil R ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Breast cancer; Chromogenic in situ hybridization; Comparative genomic hybridization; Microarrays; Molecular genetics; Pleomorphic lobular carcinoma

Indexed keywords

BETA CATENIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; UVOMORULIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CARCINOMA IN SITU; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INVASIVE CARCINOMA; LUNG CARCINOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CHROMOSOME ABERRATIONS; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MICRODISSECTION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 23944451152     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1806     Document Type: Article

References (36)

1. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005;205:248-254.
2. Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003;5:313-319.
3. Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003;5:258-262.
4. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002;15:1044-1050.
5. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 2001;25:237-244.
6. Maluf HM. Differential diagnosis of solid carcinoma in situ. Semin Diagn Pathol 2004;21:25-31.
7. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 2001;115:534-542.
8. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001; 25:229-236.
9. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 1999;187:396-402.
10. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999;189:521-526.
11. Cleton-Jansen AM, Buerger H, Haar N, Philippo K, van de Vijver MJ, Boecker W, et al. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004;41:109-116.
12. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997; 74:513-517.
13. Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung BM, Waldman FM. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 2001;32:292-296.
14. Shelley Hwang E, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100:2562-2572.
15. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000;24:1650-1656.
16. Palacios J, Sarrio D, Garcia-Macias MC, Bryant B, Sobel ME, Merino MJ. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 2003;16:674-678.
17. Eusebi V, Betts C, Haagensen DE Jr, Gugliotta P, Bussolati G, Azzopardi JG. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. Hum Pathol 1984;15:134-140.
18. Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 1992;23:655-662.
19. Weidner N, Semple JP. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992;23:1167-1171.
20. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Steele D, et al. Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue. J Pathol 2004;202:274-285.
21. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane J, et al. Columnar cell lesions of the breast - the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005;29:734-746.
22. Jones C, Ford E, Gillett C, Ryder K, Merrett S, Reis-Filho JS, et al. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res 2004;10:5988-5997.
23. Greshock J, Naylor TL, Margolin A, Diskin S, Cleaver SH, Futreal PA, et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 2004;14:179-187.
24. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004;20:3413-3422.
25. Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, et al. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res 2004; 64:8541-8549.
26. Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 2000;157:1467-1472.
27. Nyante SJ, Devries S, Chen YY, Hwang ES. Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer. Hum Pathol 2004; 35:759-763.
28. Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005; 18:741-751.
29. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001;92:404-408.
30. Roylance R, Droufakou S, Gorman P, Gillett C, Hart IR, Hanby A, Tomlinson I. The role of E-cadherin in low-grade ductal breast tumourigenesis. J Pathol 2003;200:53-58.
31. Chen Y, Fitzgibbons P, Jacobs T, MacGrogan G, Peterse H, Vincent-Salomon A, et al. Pleomorphic apocrine lobular carcinoma in situ (PALCIS): phenotypic and genetic study of a distinct variant of lobular carcinoma in situ (LCIS). Mod Pathol 2005;18:118.
32. Hwang ES, DeVries S, Chew KL, Moore DH II, Kerlikowske K, Thor A, et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 2004; 10:5160-5167.
33. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998;58:4721-4727.
34. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003;106:208-215.
35. Sarrio D, Perez-Mies B, Hardisson D, Moreno-Bueno G, Suarez A, Cano A, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from pre-invasive to metastatic lesions. Oncogene 2004;23:3272-3283.
36. Robanus-Maandag EC, Bosch CA, Kristel PM, Hart AA, Faneyte IF, Nederlof PM, et al. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. J Pathol 2003;201:75-82.